Moderna's Vaccine Portfolio Primed For Boost From Its COVID-19 Work

 
• By Brenda Sandburg
Stone / United Kingdom - February 11 2020: Moderna medical compamy logo seen on the brochure with the viral masks, syringe and pills. Photo concept. Selective focus.
Moderna touts its messenger RNA and vaccines pipline to investors

More from COVID-19

More from Scrip